259 filings
10-Q
2024 Q1
SAGE
Sage Therapeutics Inc
Quarterly report
25 Apr 24
7:15am
8-K
SAGE
Sage Therapeutics Inc
25 Apr 24
Sage Therapeutics Announces First Quarter 2024 Financial Results and Highlights Pipeline and Business Progress
6:46am
ARS
2023 FY
SAGE
Sage Therapeutics Inc
24 Apr 24
Annual report to shareholders
4:13pm
DEFA14A
SAGE
Sage Therapeutics Inc
24 Apr 24
Additional proxy soliciting materials
4:10pm
DEF 14A
SAGE
Sage Therapeutics Inc
Definitive proxy
24 Apr 24
4:07pm
8-K
3xhwaq23wk c7
19 Apr 24
Departure of Directors or Certain Officers
8:31am
8-K
pn604idtnu61 bpdre
17 Apr 24
Regulation FD Disclosure
6:35am
SC TO-I/A
tj6zw4mlv391z8u
27 Mar 24
Issuer tender offer statement (amended)
4:09pm
8-K
u8t4r3kgun0xs2m9nn
26 Mar 24
Departure of Directors or Certain Officers
8:34am
SC TO-I/A
oq4w18
21 Feb 24
Issuer tender offer statement (amended)
4:35pm
SC TO-I/A
2273dtez
14 Feb 24
Issuer tender offer statement (amended)
4:09pm
S-8
uuiodtex2le275uzb9y
14 Feb 24
Registration of securities for employees
7:49am
8-K
j8zf nlku
14 Feb 24
Sage Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Highlights Pipeline and Business Progress
6:45am
SC TO-I/A
zksyci8uodf0p6t
31 Jan 24
Issuer tender offer statement (amended)
5:25pm
8-K
l6nf41
31 Jan 24
Submission of Matters to a Vote of Security Holders
4:50pm
8-K
9ahkdq2b
24 Jan 24
Entry into a Material Definitive Agreement
4:10pm
SC TO-I
d1ub9l22c
23 Jan 24
Issuer tender offer statement
8:13am
8-K
f3svl5o2znrp0iih0lz4
8 Jan 24
Departure of Directors or Certain Officers
6:45am
DEFA14A
3tik3z7sj
19 Dec 23
Additional proxy soliciting materials
8:32am